The autoimmunity-associated PTPN22 variant promotes NLRP3 activity, caspase-1 activation, and secretion of IL-1β and IL18, which might—at least partially—explain the pro-inflammatory character of this PTPN22 variant in T1D, RA and SLE development. This evidence concerns the gene NLRP3 and Autoimmunity.